Stephanie Halver felt she had done everything correctly to protect her health. Given her family history of breast cancer, her age, and dense breast tissue, her doctor recommended an annual breast MRI as a critical safeguard to catch what a standard mammogram might miss. After her insurance provider, Blue Cross Blue Shield of Texas, preapproved the procedure, Halver went ahead with the scan last September. She was relieved when the results came back clear, but that relief vanished when she opened her mail to find a bill for over 1,200 dollars.
The shock stemmed from a frustrating gap between medical necessity and insurance definitions. While the Affordable Care Act mandates that insurers cover preventive care without cost to the patient, not all preventive tests are viewed equally by federal regulators. In Halver’s case, the U.S. Preventive Services Task Force does not currently categorize MRIs for women with dense breasts and normal mammograms as a mandatory free service due to insufficient evidence regarding their overall benefit versus potential harm. Because Halver’s initial mammogram was clear, the MRI was treated as a taxable expense rather than a free preventive screen.
This bureaucratic distinction creates a precarious situation for high risk patients. According to Cathy Peters of the American Cancer Society Cancer Action Network, while some states have passed laws requiring coverage for these scans, those laws rarely apply to employees with large self insured plans regulated by federal law rather than state statutes. This leaves many women in a position where they receive prior authorization for a test—meaning the insurer agrees it is medically necessary—but that approval does not guarantee that the insurer will actually foot the bill.
For Halver, the resolution provided little comfort. After appealing the decision and consulting her employer’s human resources department, she discovered that while mammograms remain free under her plan, MRIs are subject to her thousands of dollars in annual deductibles and coinsurance. Now facing a recurring annual cost for a life saving screening, Halver serves as a cautionary tale for others who assume that an approved appointment equals zero out of pocket costs.
